These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 10390595

  • 21. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
    Aizawa Y, Yoshida K, Kaise N, Kaise K, Fukazawa H, Kiso Y, Mori K, Sayama N, Kikuchi K, Abe K.
    Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
    [Abstract] [Full Text] [Related]

  • 22. Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy.
    Takamura Y, Nakano K, Uruno T, Ito Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma K, Miyauchi A.
    Endocr J; 2003 Oct; 50(5):595-601. PubMed ID: 14614216
    [Abstract] [Full Text] [Related]

  • 23. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H, Kasagi K, Morita T, Hidaka A, Kuma K, Konishi J, Kumagai LF, Nagataki S.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.
    Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N.
    Endocr J; 2005 Oct; 52(5):505-10. PubMed ID: 16284425
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Significance of values of thyrotropin binding inhibitor immunoglobulins and appearance of intrathyroidal lymphocytes at subtotal thyroidectomy for Graves' disease.
    Kasuga Y, Sugenoya A, Kobayashi S, Shimizu T, Onuma H, Shingu K, Asanuma K, Hama Y, Iida F.
    J Am Coll Surg; 1994 Jun; 178(6):589-94. PubMed ID: 7910771
    [Abstract] [Full Text] [Related]

  • 31. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
    Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A.
    Surgery; 1996 Dec; 120(6):1020-4; discussion 1024-5. PubMed ID: 8957489
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Results of subtotal thyroidectomy for Graves' disease.
    Chou FF, Wang PW, Huang SC.
    Thyroid; 1999 Mar; 9(3):253-7. PubMed ID: 10211601
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy.
    Kurihara H.
    Thyroid; 2002 Mar; 12(3):265-7. PubMed ID: 11952051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.